Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Detection of Epstein-Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts.

Kleer CG, Tseng MD, Gutsch DE, Rochford RA, Wu Z, Joynt LK, Helvie MA, Chang T, Van Golen KL, Merajver SD.

Mod Pathol. 2002 Jul;15(7):759-64.

2.

Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model.

Tan J, Newton CA, Djeu JY, Gutsch DE, Chang AE, Yang NS, Klein TW, Hua Y.

Cancer Res. 1996 Aug 1;56(15):3399-403.

3.

The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters.

Gutsch DE, Marcu KB, Kenney SC.

Cell Mol Biol (Noisy-le-grand). 1994 Sep;40(6):747-60.

PMID:
7812182
4.

The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B.

Gutsch DE, Holley-Guthrie EA, Zhang Q, Stein B, Blanar MA, Baldwin AS, Kenney SC.

Mol Cell Biol. 1994 Mar;14(3):1939-48.

5.

The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor.

Zalani S, Holley-Guthrie EA, Gutsch DE, Kenney SC.

J Virol. 1992 Dec;66(12):7282-92.

6.

Development of glutathione peroxidase activity during dietary and genetic copper deficiency.

Prohaska JR, Gutsch DE.

Biol Trace Elem Res. 1983 Feb;5(1):35-45. doi: 10.1007/BF02916925.

PMID:
24263367

Supplemental Content

Loading ...
Support Center